Likun Wang
Director
Jiangsu Hengrui Medicine Co., Ltd
China
Biography
Likun got his Bachelor’s degree in Biomedical Devices and PhD in Industry Pharmacy with focus on PAT, imaging, pelletization and coating process. Likun Joined Johnson & Johnson Pharmaceutical Research & Development (Belgium Site) in 2011 and act as scientist to develop and manage automated screening platforms for early development. In 2014, Likun became senior scientist and preformation group leader for automated screening and early development. In 2015, Likun joined Jiangsu Hengrui Medical co. as NanJing R&D site director and returned to China. Hengrui Nanjing R&D site is responsible for preformuation & early development for NMEs, formulation innovation for generics as well as external collaborations and innovation with Universities and research Institutes.
Research Interest
Preformulation & early development, Polymorphism & Salt, Enabling formulation & Processing of small molecules (Amorphous Solid Dispersion, Nano-suspensions, Lipid system), High throughput screening, Biopharmaceutics & PBPK Modeling, Material Characterizaiton & Physical Stability, Controlled Release formulation development, Chemometrics & PAT, Fundamental Understanding of physical stability